Science

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors – The Babak Lab

The Babak Lab/LinkedIn

Mar 22, 2025, 07:56

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors – The Babak Lab

The Babak Lab shared an article by Meng Rui Chang, et al. on LinkedIn:

“Read our paper in JACS (American Chemical Society)!

The Babak Lab in collaboration with Prof. Wee Han Ang, Prof. Walter Berger and City University of Hong Kong.”

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors.

Authors: Meng Rui Chang, et al.

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab

Maria (Masha) Babak, Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong, shared the post on LinkedIn, adding:

“I am deeply honored to be able to publish in JACS (American Chemical Society society)!

This work would not be possible without the help of my students, colleagues and mentors. Also I would like to specially thank reviewers for their extremely valuable comments that made this paper much better!

I am very happy.”

American Chemical Society cancer cell death City University of Hong Kong fight against cancer Global fight against cancer JACS Maria (Masha) Babak Meng Rui Chang Mesothelioma Tumors OncoDaily Oncology The Babak Lab Walter Berger Wee Han Ang

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

John Cena Announces He Overcame Skin Cancer Twice, Advocates for Sun Safety